Most recent update: Wednesday, April 1, 2020 - 08:35

Bariatric News - Cookies & privacy policy

You are here

News

12/02/20 - Policy
Endocrine obesity guidelines
European Society of Endocrinology has published guidelines recommending testing for all patients with obesity for thyroid function (given the high prevalence of hypothyroidism in obesity). The...
11/02/20 - Policy
NICE consultation
In a consultation document, the UK’s National Institute for Health and Care Excellence has decided not to recommend liraglutide (Saxenda, Novo Nordisk), within its marketing authorisation, for...
07/02/20 - Policy
Waist circumference and obesity
Healthcare professionals should routinely measure waist circumference alongside BMI to properly assess and manage obesity-related health risk, according to a Consensus Statement from the...
04/02/20 - Policy
2020 Obesity Algorithm
The Obesity Medicine Association (OMA) has announced the immediate availability of the 2020 OMA Obesity Algorithm, with new information for clinicians including obesity myths, polycystic ovary...
11/09/19 - Policy
MBSAQIP programme
The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), a joint quality programme of the American College of Surgeons (ACS) and the American Society for Metabolic...
01/04/20 - Policy
COVID-19
As patients with Coronavirus Disease 2019 (COVID-19) flood hospitals, the health care system must not only determine how to redeploy limited resources and staff to care for them but must also make...
05/03/20 - Policy
Obesity stigma
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, according to Dr Stuart Flint, Associate Professor in the...
14/02/20 - Policy
Belviq withdrawn
The FDA has requested that Eisai - the manufacturer of Belviq, Belviq XR (lorcaserin) - voluntarily withdraws the weight-loss drug from the US market because a safety clinical trial has showed an...

Monthly archive